Article info

PDF

Original article
Phase IIb multicentred randomised trial of besifovir (LB80380) versus entecavir in Asian patients with chronic hepatitis B

Authors

  1. Correspondence to Professor Man-Fung Yuen, Department of Medicine, The University of Hong Kong, Hong Kong; mfyuen{at}hkucc.hku.hk and Professor Kwang-Hyub Han, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea; gihankhys{at}yumc.yonsei.ac.kr
View Full Text

Citation

Lai C, Ahn SH, Lee KS, et al
Phase IIb multicentred randomised trial of besifovir (LB80380) versus entecavir in Asian patients with chronic hepatitis B

Publication history

  • Received April 22, 2013
  • Revised August 5, 2013
  • Accepted August 6, 2013
  • First published August 26, 2013.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.